The diisopropylfluorophosphate inhibitable step in antigen-induced histamine release from human leukocytes
- PMID: 46264
The diisopropylfluorophosphate inhibitable step in antigen-induced histamine release from human leukocytes
Abstract
DFP inhibits early events in antigen-induced histamine release from human leukocytes. If added to cells 5 min or more after antigen it is ineffective. If added with antigen it can be removed at 5 min but release will still be inhibited. In contrast, ethylenediaminetetraacetate (EDTA) and 2 deoxyglucose (2DG) still inhibit the reactions when added 5 min after antigen. During incubation of leukocytes for 90 to 120 min at 0 degrees C they react with specific antigen since they subsequently release significant quantities of histamine after washing and reincubation at 37 degrees C without addition of antigen. Such priming at 0 degrees C is at least equivalent to priming for 2 to 4 min at 37 degrees C. During antigen priming at 0 degrees C the cells are not activated beyond the step in the release sequence which is inhibited by diisopropylfluorophosphate (DFP). This is apparent from the undiminished inhibitory activity of DFP on these cells. Furthermore, cells primed with antigen at 0 degrees C in the presence of DFP release as much histamine after washing and incubation at 37 degrees D as control cells primed in the absence of DFP. Incubation of leukocytes with specific antigen at 37 degrees C for 3 min resulted in significant but not quite complete priming for subsequent histamine release in the absence of antigen. Most of these primed cells were not activated beyond the step inhibitable by DFP. However, some had completed the entire sequence including the release of histamine while others had not released their histamine but were not inhibited by DFP from subsequent release. After 5 min incubation with antigen at 37 degrees C almost all leukocytes had progressed beyond the stage which is inhibited by DFP. Incubation of leukocytes at 37 degrees C with DFP but without antigen for up to 15 min followed by washing did not impair subsequent antigen-induced histamine release by these cells. Thus, DFP was inhibitory under these conditions only after antigen activation of leukocytes.
Similar articles
-
Complement-induced histamine release from human basophils. II. Mechanism of the histamine release reaction.J Immunol. 1976 Mar;116(3):639-46. J Immunol. 1976. PMID: 56398
-
Diisopropylfluorophosphate-evoked inhibition of anaphylactic histamine release from human skin: decrease of the inhibition by storing the skin specimens.Acta Derm Venereol. 1979;59(2):121-4. Acta Derm Venereol. 1979. PMID: 84487
-
Granule-associated serine neutral proteases of the mouse bone marrow-derived mast cell that degrade fibronectin: their increase after sodium butyrate treatment of the cells.J Immunol. 1984 Sep;133(3):1535-41. J Immunol. 1984. PMID: 6205085
-
A sequence of biochemical events in the antigen-induced release of chemical mediators from sensitized human lung tissue.J Exp Med. 1973 Nov 1;138(5):1077-94. doi: 10.1084/jem.138.5.1077. J Exp Med. 1973. PMID: 4126764 Free PMC article.
-
Diisopropylfluorophosphate-P32 (DFP-P32) as a label for granulocytes.Adv Tracer Methodol. 1965;2:261-6. doi: 10.1007/978-1-4684-8622-3_30. Adv Tracer Methodol. 1965. PMID: 5334301 Review. No abstract available.
Cited by
-
A linear correlation between histamine release and degranulation of human basophils by specific antigen or the ionophore A23187.Immunology. 1980 Jul;40(3):411-6. Immunology. 1980. PMID: 6159310 Free PMC article.
-
Modulation of chymase-mediated rat serosal mast cell degranulation by trypsin or diisopropyl fluorophosphate.Immunology. 1989 Mar;66(3):434-8. Immunology. 1989. PMID: 2522909 Free PMC article.
-
Human mast cells and basophils--structure, function, pharmacology, and biochemistry.Clin Rev Allergy. 1983 Sep;1(3):327-41. doi: 10.1007/BF02991224. Clin Rev Allergy. 1983. PMID: 6201252 Review. No abstract available.